ISO BLOCK PRODUCTS USA INC
8-K, 2000-08-18
STRUCTURAL CLAY PRODUCTS
Previous: MASTER REALTY PROPERTIES INC, 10-Q, 2000-08-18
Next: ISO BLOCK PRODUCTS USA INC, 8-K, EX-2, 2000-08-18



                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549




                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934


       Date of report (Date of earliest event reported): August 16, 2000.



                          ISO BLOCK PRODUCTS USA, INC.
             (Exact Name of Registrant as Specified in Its Charter)




        Colorado                       0-25810                   84-1206503
   (State or Other              (Commission File Number)     (I.R.S. Employee
Jurisdiction of Incorporation)                            Identification Number)


                     2250 North 1500 West, Ogden, Utah 84404
          (Address of Principal Executive Offices, Including Zip Code)


                                 (801) 395-2796
              (Registrant's Telephone Number, Including Area Code)

                          ISO Block Products USA, Inc.
                8037 S. Datura Street, Littleton, Colorado 80120
          (Former Name or Former Address, if Changed Since Last Report)






<PAGE>



ITEM 1.           CHANGES IN CONTROL OF REGISTRANT.

                  Effective  August 16, 2000,  ISO Block Products USA, Inc. (the
"Company" or the "Registrant"), underwent a change of control in connection with
its acquisition of Cryocon, Inc., a Utah corporation ("Cryocon"), in a stock for
stock  exchange,  as more fully described below under Item 2. As a result of the
stock  exchange,  (i) persons  designated by Cryocon  constituted  the Company's
board of  directors,  and (ii) the former  shareholders  of  Cryocon  became the
holders of 44,000,000 shares of the Company's common stock, out of approximately
49,000,000 shares issued and outstanding following the exchange.

                  Following the  exchange,  Robert W.  Brunson,  Debra  Brunson,
Harry Brunson and Randy Sant, all designees of Cryocon,  became directors of the
Company,  and Egin Bresnig,  Karin  Kuhbander,  and Dean Wicker  resigned  their
positions as directors of the  Registrant.  On July 20, 2000,  the Company filed
with the Securities and Exchange Commission an information statement pursuant to
Rule 14f-1 under the  Securities  Exchange Act of 1934, as amended,  which among
other  things  described  the  impending  stock  exchange and change of control.
Biographical  information  concerning  the new  directors  is set  forth in that
information statement.

ITEM 2.           ACQUISITION OR DISPOSITION OF ASSETS.

                  On April 25,  2000,  the Company and Cryocon  entered  into an
Agreement  and  Plan of  Reorganization  (the  "Agreement"),  providing  for the
Company's  purchase of all the outstanding  capital stock of Cryocon in exchange
for the  Company's  issuance  of  44,000,000  shares of its common  stock to the
holders of the Cryocon  shares.  The share  exchange is intended to qualify as a
tax-free  reorganization  pursuant  to  Sections  351  and  368(a)(1)(B)  of the
Internal Revenue Code of 1986, as amended.

                  Further  information  concerning  Cryocon  is set forth in the
information  statement  filed by the Company on July 20, 2000. The Agreement and
Plan of Reorganization is filed as an exhibit to this report.


ITEM 7.      FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.

                  (a)      Financial Statements of Business Acquired

                           The audited  financial  statements  of Cryocon  Inc.,
consisting  of balance  sheet  dated as of March 31,  2000,  and  statements  of
operations,  stockholders'  equity  (deficit) and cash flows for the period from
inception  (October 20, 1999) through March 31, 2000,  together with  footnotes,
are set forth beginning at page F-1.

                  (b)      Pro Forma Financial Information

                           The pro forma  financial  information  required to be
disclosed  hereunder  will be filed by amendment to this initial  report on form
8-K not later than 60 days after the date by which this  initial  report must be
filed.

                  (c)      Exhibits

                           The  following  exhibits are included as part of this
report:
<PAGE>

                  2.1  Agreement and Plan of  Reorganization,  dated as of April
25, 2000, by and among the Company, Cryocon Inc. and the shareholders of Cryocon
Inc.


                                   SIGNATURES


                  Pursuant to the requirements of the Securities Exchange Act of
1934,  the  Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.


                                            ISO BLOCK PRODUCTS USA, INC.




Date:  August __, 2000                      By: /s/ Robert W. Brunson
                                            --------------------------------
                                                 Name:  Robert W. Brunson
                                                 Title: President




<PAGE>




                                  CRYOCON, INC.
                          (A Development Stage Company)

                              FINANCIAL STATEMENTS

                                 March 31, 2000


<PAGE>






                                 C O N T E N T S


Independent Auditors' Report........................................... F - 3

Balance Sheet.......................................................... F - 4

Statement of Operations................................................ F - 5

Statement of Stockholders' Equity (Deficit)............................ F - 6

Statement of Cash Flows................................................ F - 8

Notes to the Financial Statements...................................... F - 9




                                      F-2
<PAGE>







                          INDEPENDENT AUDITORS' REPORT
                          ----------------------------

To the Stockholders of
Cryocon, Inc.
(A Development Stage Company)
Ogden, Utah


We have audited the accompanying  balance sheet of Cryocon,  Inc. (a development
stage  company) as of March 31, 2000 and the related  statements of  operations,
stockholders' equity (deficit) and cash flows from inception on October 20, 1999
through March 31, 2000. These financial statements are the responsibility of the
Company's  management.  Our  responsibility  is to  express  an opinion on these
financial statements based on our audit.

We conducted our audit in accordance with generally accepted auditing standards.
Those standards  require that we plan and perform the audit to obtain reasonable
assurance   about  whether  the  financial   statements  are  free  of  material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing the  accounting  principles  used and  significant  estimates  made by
management,  as well as evaluating the overall financial statement presentation.
We believe that our audit provides a reasonable basis for our opinion.

In our opinion,  the financial  statements  referred to above present fairly, in
all material respects,  the financial  position of Cryocon,  Inc. (a development
stage  company) as of March 31, 2000 and the results of its  operations  and its
cash  flows from  inception  on  October  20,  1999  through  March 31,  2000 in
conformity with generally accepted accounting principles.

The  accompanying  financial  statements  have been  prepared  assuming that the
Company  will  continue  as a  going  concern.  As  discussed  in  Note 6 to the
financial  statements,  the  Company  is a  development  stage  company  with no
significant  operating  results to date, which raise substantial doubt about its
ability to continue as a going  concern.  Management's  plans in regard to these
matters are also  described in Note 6. The  financial  statements do not include
any adjustments that might result from the outcome of the uncertainty.



HJ & Associates, LLC
Salt Lake City, Utah
July 14, 2000

                                      F-3
<PAGE>


                                  CRYOCON, INC.
                          (A Development Stage Company)
                                  Balance Sheet
                                     ASSETS
                                     ------

<TABLE>
<CAPTION>

                                                                            March 31,
                                                                                 2000
                                                                            ---------
<S>                                                                     <C>

CURRENT ASSETS

   Cash                                                                 $          71,771
   Accounts receivable, net                                                        12,611
                                                                        -----------------

     Total Current Assets                                                          84,382

PROPERTY AND EQUIPMENT, NET (Note 2)                                            2,260,585
                                                                        -----------------

OTHER ASSETS

   Patents, trademarks and licenses, net (Note 1)                                 419,067
                                                                        -----------------

     Total Other Assets                                                           419,067
                                                                        -----------------

     TOTAL ASSETS                                                       $       2,764,034
                                                                        =================

                 LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
                 ----------------------------------------------

CURRENT LIABILITIES

   Accounts payable                                                     $          75,705
   Accrued expenses                                                                80,320
   Current portion long-term debt (Note 4)                                      2,863,149
                                                                        -----------------

     Total Current Liabilities                                                  3,019,174
                                                                        -----------------

LONG-TERM LIABILITIES

   Note payable, related party (Note 3)                                            50,000
   Long-term debt (Note 4)                                                        187,291
                                                                        -----------------

     Total Long-Term Liabilities                                                  237,291
                                                                        -----------------

     TOTAL LIABILITIES                                                          3,256,465
                                                                        -----------------

STOCKHOLDERS' EQUITY (DEFICIT)

   Common stock: 20,000,000 shares authorized of no
    par value, 11,000,000 shares issued and outstanding                           577,500
   Deficit accumulated during the development stage                            (1,069,931)
                                                                        -----------------

     Total Stockholders' Equity (Deficit)                                        (492,431)
                                                                        -----------------

     TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)               $       2,764,034
                                                                        =================

</TABLE>

   The accompanying notes are an integral part of these financial statements.
                                      F-4
<PAGE>

                                  CRYOCON, INC.
                          (A Development Stage Company)
                             Statement of Operations
<TABLE>
<CAPTION>



                                                                                          From
                                                                                  Inception on
                                                                                   October 20,
                                                                                  1999 Through
                                                                                     March 31,
                                                                                          2000
                                                                             -----------------
<S>                                                                          <C>

REVENUES

   Sales                                                                     $          22,505
                                                                             -----------------

COST OF SALES

   Supplies and materials                                                                6,979
                                                                             -----------------

GROSS MARGIN                                                                            15,526
                                                                             -----------------

EXPENSES

   Advertising                                                                          53,524
   Depreciation and amortization                                                        42,299
   General and administrative                                                          963,490
                                                                             -----------------

     Total Expenses                                                                  1,059,313
                                                                             -----------------

OPERATING LOSS                                                                      (1,043,787)
                                                                             -----------------

OTHER (EXPENSE)

   Interest expense                                                                    (26,144)
                                                                             -----------------

     Total Other (Expense)                                                             (26,144)
                                                                             -----------------

NET LOSS                                                                     $      (1,069,931)
                                                                             =================

BASIC LOSS PER SHARE                                                         $           (0.31)
                                                                             =================

FULLY DILUTED LOSS PER SHARE                                                 $           (0.31)
                                                                             =================

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING                                        3,472,710
                                                                             =================
</TABLE>
  The accompanying notes are an integral part of these financial statements.

                                      F-5
<PAGE>


                                  CRYOCON, INC.
                          (A Development Stage Company)
                   Statement of Stockholders' Equity (Deficit)
<TABLE>
<CAPTION>


                                                                                                  Deficit
                                                                                                 Accumulated
                                                                   Common Stock                   During the
                                                              --------------------------         Development
                                                              Shares              Amount           Stage
                                                              ------              ------         -----------
<S>                                                    <C>                 <C>                 <C>

Balance at inception on
 October 20, 1999                                                  -       $           -       $          -

Issuance of common stock to founders
 for services at $0.00 per share                                    1,000              -                  -

Issuance of common stock to founders
 for services at $0.00 per share                                  524,000              -                  -

Issuance of common stock to founders
 for services and intangible assets at
 $0.00 per share                                                9,700,000              -                  -

Issuance of common stock for services
 at $0.75 per share                                               100,000              75,000             -

Issuance of common stock for cash
 at $0.50 per share                                                10,000               5,000             -

Issuance of common stock for services
 at $0.50 per share                                                 5,000               2,500             -

Issuance of common stock for cash
 at $0.50 per share                                                10,000               5,000             -

Issuance of common stock for cash
 at $0.50 per share                                                 4,000               2,000             -

Issuance of common stock for services
 at $0.50 per share                                                16,000               8,000             -

Issuance of common stock for services
 at $0.75 per share                                               100,000              75,000             -

Issuance of common stock for services
 at $0.75 per share                                               500,000             375,000             -

Issuance of common stock for cash at
 $1.00 per share                                                   10,000              10,000             -
                                                       ------------------  ------------------  -----------------

Balance forward                                                10,980,000  $          557,500  $          -
                                                       ------------------  ------------------  -----------------
</TABLE>
  The accompanying notes are an integral part of these financial statements.

                                      F-6
<PAGE>


                                  CRYOCON, INC.
                          (A Development Stage Company)
             Statement of Stockholders' Equity (Deficit) (Continued)
<TABLE>
<CAPTION>


                                                                                                  Deficit
                                                                                                 Accumulated
                                                                   Common Stock                   During the
                                                              --------------------------         Development
                                                              Shares              Amount           Stage
                                                              ------              ------         -----------

<S>                                                    <C>                 <C>                 <C>

Balance forward                                                10,980,000  $          557,500  $          -

Issuance of common stock for cash
 at $1.00 per share                                                10,000              10,000             -

Issuance of common stock for cash
 at $1.00 per share                                                10,000              10,000             -

Net loss from inception on
 October 20, 1999 through
 March 31, 2000                                                    -                   -              (1,069,931)
                                                       ------------------  ------------------  -----------------

Balance, March 31, 2000                                        11,000,000  $          577,500  $      (1,069,931)
                                                       ==================  ==================  =================
</TABLE>


  The accompanying notes are an integral part of these financial statements.

                                      F-7



<PAGE>


                                  CRYOCON, INC.
                          (A Development Stage Company)
                             Statement of Cash Flows

<TABLE>
<CAPTION>

                                                                                                            From
                                                                                                    Inception on
                                                                                                     October 20,
                                                                                                    1999 Through
                                                                                                       March 31,
                                                                                                            2000
                                                                                               -----------------

<S>                                                                                            <C>

CASH FLOWS FROM OPERATING ACTIVITIES

   Net (loss)                                                                                  $      (1,069,931)
   Adjustments to reconcile net loss to net cash used by operating
     activities;
     Amortization and depreciation                                                                        42,299
     Common stock issued for services rendered                                                           535,500
   (Increase) decrease in:
     Accounts receivable                                                                                 (12,611)
     Accounts payable and accrued expenses                                                               156,025
                                                                                               -----------------

       Net Cash Used by Operating Activities                                                            (348,718)
                                                                                               -----------------

CASH FLOWS FROM INVESTING ACTIVITIES

   Purchase or development of intangibles                                                               (449,000)
   Equipment purchases                                                                                  (222,951)
   Purchase of building                                                                               (2,050,000)
                                                                                               -----------------

       Net Cash (Used) by Investing Activities                                                        (2,721,951)
                                                                                               -----------------

CASH FLOWS FROM FINANCING ACTIVITIES

   Issuance of common stock for cash                                                                      42,000
   Issuance of notes payable                                                                           3,105,846
   Payments made on notes payable                                                                         (5,406)
                                                                                               -----------------

       Net Cash Provided by Financing Activities                                                       3,142,440
                                                                                               -----------------

NET INCREASE IN CASH AND CASH EQUIVALENTS                                                                 71,771

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD                                                          -
                                                                                               -----------------

CASH AND CASH EQUIVALENTS AT END OF PERIOD                                                     $          71,771
                                                                                               =================

CASH PAID FOR:

   Interest                                                                                    $           3,944
   Income taxes                                                                                $          -

Schedule of Non-Cash Financing Activities:

   Common stock issued for services                                                            $         535,500
</TABLE>
  The accompanying notes are an integral part of these financial statements.

                                      F-8
<PAGE>


                                  CRYOCON, INC.
                          (A Development Stage Company)
                        Notes to the Financial Statements
                                 March 31, 2000


NOTE 1 -          SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

         General Information
         -------------------

              Cryocon,  Inc.  (the  Company)  is a  privately  held  corporation
              organized under the laws of the State of Utah in October 1999. The
              Company's  authorized  capital stock consists of 20,000,000 shares
              of common stock,  with no par value,  of which  11,000,000  shares
              have been issued and are  outstanding,  and no shares of preferred
              stock are authorized.  All of the Company's  shares have been duly
              authorized, validly issued, and are fully paid and non-assessable.
              The Company is engaged in the study of extremely low  temperatures
              and how materials react to those temperatures and treating various
              materials    with   those    temperatures    to   improve    their
              characteristics.

         Revenue Recognition
         -------------------

              Revenue  is  recognized  on an accrual  basis when the  product is
              shipped.

         Property and Equipment
         ----------------------

              Property and  equipment are stated at cost with  depreciation  and
              amortization  computed on the straight-line  method.  Property and
              equipment  are  depreciated  over the following  estimated  useful
              lives:

                                                                      Years
                                                                      -----
                           Office furniture                            5-10
                           Machinery and equipment                        5
                           Building                                    39.5
                           Shop equipment                                10


               Patents, Trademarks and Licenses
               --------------------------------
<TABLE>
<CAPTION>


                                                                                                      Net Book
                                                                                                       Value
                                                 Term              Cost              Amortization       2000
                                            ----------------  ------------------  ---------------  ----------------
               <S>                          <C>               <C>                 <C>              <C>

               Product rights                   5 years       $          100,000  $         6,666  $         93,334
               Customer lists, patents
                  and trademarks                5 years                  349,000           23,267           325,733
                                            ----------------  ------------------  ---------------  ----------------

                                                              $          449,000  $        29,933  $        419,067
                                                              ==================  ===============  ================
</TABLE>

              Product rights,  customer lists,  patents and trademarks have been
              capitalized  and  amortized  over five years using a straight line
              method.  The total  amortization of production  costs for the year
              ended March 31, 2000 amounted to $29,933

              The  Company  evaluates  the  recoverability  of  intangibles  and
              reviews  the  amortization  period  on an  annual  basis.  Several
              factors  are  used to  evaluate  intangibles,  including,  but not
              limited  to,  management's  plans for  future  operations,  recent
              operating results and projected, undiscounted cash flows.



                                      F-9


<PAGE>



                                  CRYOCON, INC.
                          (A Development Stage Company)
                          Notes to Financial Statements
                                 March 31, 2000


NOTE 1 -      SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

              Basic Loss Per Share
              --------------------

                                    For the Year Ended
                                      March 31, 2000
                       -----------------------------------------------------
                           Loss               Shares             Per Share
                        (Numerator)         (Denominator)        Amount
                       -----------         -------------    -----------------

                   $       (1,069,931) $        3,472,710  $           (0.31)
                   ==================  ==================  =================



              Cash Flows
              ----------

              For purposes of reporting  cash flows,  cash and cash  equivalents
              include cash on hand and cash on deposit with banks.

              Income Taxes
              ------------

              The  Company's  tax basis is the same as the  Company's  financial
              statement basis. The Company has net operating loss  carryforwards
              of approximately $1,070,000 available to offset future federal and
              state income tax through 2020.  The Company has not recorded a tax
              benefit  attributable to the carryforwards  because realization of
              such has been offset by a valuation allowance for the same amount.

              Production Costs
              ----------------

              The  Company  classifies  the  costs of  planning,  designing  and
              establishing the  technological  feasibility of development  costs
              and  charges  those  costs  to  expense  when  incurred.  Costs of
              maintenance and customer support are charged to expense when costs
              are incurred.

              Advertising
              -----------

              The  Company   follows  the  policy  of  charging   the  costs  of
              advertising to expense as incurred.

              Estimates
              ---------

              The  preparation  of  financial   statements  in  conformity  with
              generally accepted  accounting  principles  requires management to
              make estimates and assumptions that affect the reported amounts of
              assets and  liabilities  and  disclosure of contingent  assets and
              liabilities  at the  date  of the  financial  statements  and  the
              reported  amounts of revenues  and expenses  during the  reporting
              period. Actual results could differ from those estimates.


                                      F-10
<PAGE>


                                  CRYOCON, INC.
                          (A Development Stage Company)
                        Notes to the Financial Statements
                                 March 31, 2000


NOTE 1 -      SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

              Change in Accounting Principles
              -------------------------------

              The Company adopted  Statement of Financial  Accounting  Standards
              (SFAS) No. 128,  "Earnings  Per Share" during the year ended March
              31, 2000. In accordance  with SFAS No. 128,  diluted  earnings per
              share  must  be   calculated   when  an  entity  has   convertible
              securities, warrants, options, and other securities that represent
              potential  common  shares.  The  purpose  of  calculating  diluted
              earnings  (loss)  per share is to show (on a  proforma  basis) per
              share  earnings or losses  assuming the exercise or  conversion of
              all securities  that are  exercisable  or convertible  into common
              stock and that would either dilute or not affect basis of EPS.

NOTE 2 -      PROPERTY AND EQUIPMENT

              Property  and  equipment  as of March 31, 2000 are detailed in the
              following summary:

<TABLE>
<CAPTION>

                                                                                                     Net Book
                                                                                 Accumulated          Value
                                                              Cost              Depreciation           2000
                                                              ----              ------------        ---------

              <S>                                       <C>                 <C>                 <C>
              Office furniture and fixtures             $          110,665  $            1,711  $          108,954
              Machinery and equipment                              103,503               1,932             101,571
              Building improvements                                  8,783                  73               8,710
              Building                                           2,050,000               8,650           2,041,350
                                                        ------------------  ------------------  ------------------

                       Total                            $        2,272,951  $           12,366  $        2,260,585
                                                        ==================  ==================  ==================
</TABLE>

              Depreciation  expense is computed principally on the straight-line
              method in amounts  sufficient to write off the cost of depreciable
              assets over their estimated useful lives. Depreciation expense for
              the year ended March 31, 2000, amounted to $12,366.

NOTE 3 -      NOTE PAYABLE - RELATED PARTY

              Note  payable to a related  party as of March 31, 2000 is detailed
              in the following summary:
<TABLE>
<CAPTION>

                                                                                                 2000
                                                                                                 ----
              <S>                                                                             <C>

              Note payable to CEO; with an interest rate of 10%;
               unsecured; is due January 3, 2003.                                             $ 50,000

                     Total related party notes payable                                               -

                     Less: current portion                                                           -

                     Long-term portion                                                        $ 50,000
                                                                                              ========

</TABLE>
                                      F-11

<PAGE>


                                  CRYOCON, INC.
                          (A Development Stage Company)
                          Notes to Financial Statements
                                 March 31, 2000


NOTE 3 -      RELATED PARTIES (Continued)

              Maturities of the related party debenture payable are as follows:

                     Period ending March 31,          2001      $         -
                                                      2002                -
                                                      2003           50,000
                                                                -----------

                                                      Total     $    50,000
                                                                ===========

NOTE 4 -      LONG-TERM DEBT

              Notes  payable as of March 31, 2000 are detailed in the  following
              summary:
<TABLE>
<CAPTION>

                                                                                                  2000
                                                                                                  ----
              <S>                                                                           <C>

              Note payable to a company; which includes
               interest at 21%; due March 2005, secured by vehicle.                         $      18,847

              Notes payable to a company; due
               December 2006, which includes interest at 8%.                                      193,593

              Convertible debentures to a company; due
               On demand, which includes interest at 8%.                                        1,038,000

              Note payable to a company due September 9, 2000,
               interest at 8%, secured by property.                                             1,800,000
                                                                                            -------------

                   Total long-term debt                                                         3,050,440

                   Less: current portion                                                        2,863,149

                   Long-term portion                                                        $     187,291
                                                                                            =============

              Maturities of long-term debt are summarized below:

                                  Period ending March 31,           2001                    $   2,863,149
                                                                    2002                           27,595
                                                                    2003                           30,325
                                                                    2004                           33,385
                                                                    2005                           36,579
                                                                    2006                           59,407
                                                                                            -------------

                                                                    Total                   $   3,050,440
                                                                                            =============
</TABLE>

NOTE 5 -      COMMON STOCK

              The Company is  authorized  to issue  20,000,000  shares of common
              stock with no par value.  In November of 1999,  10,225,000  shares
              were issued as founders  shares to  officers  for the  transfer of
              intangible assets and services valued at predecessor cost of $-0-.

                                      F-12
<PAGE>

                                  CRYOCON, INC.
                          (A Development Stage Company)
                          Notes to Financial Statements
                                 March 31, 2000


NOTE 6 -      GOING CONCERN

              The Company's  financial  statements are prepared using  generally
              accepted accounting principles applicable to a going concern which
              contemplates   the   realization  of  assets  and  liquidation  of
              liabilities in the normal course of business. However, the Company
              does not have significant cash or other material assets,  nor does
              it have an established source of revenues  sufficient to cover its
              operating costs and to allow it to continue as a going concern. It
              is the intent of the Company to acquire a publicly traded shell to
              facilitate  the raising of equity  capital.  Until that time,  the
              stockholders have committed to covering the operating costs of the
              Company.

NOTE 7 -      SUBSEQUENT EVENTS

              a.  Summary of Proposed Merger

              The Company executed an Agreement and Plan of Reorganization dated
              April 25, 2000 (the "Exchange  Agreement") with ISO BLOCK Products
              USA, Inc., a Colorado corporation ("ISO"), pursuant to which it is
              anticipated that ISO will issue  44,000,000  shares to acquire all
              of the  Company's  issued and  outstanding  common  stock from the
              existing  holders,  upon  which the  current  shareholders  of the
              Company  will  own  approximately  86%  of  ISO.  Pursuant  to the
              Exchange  Agreement,  the  existing  board of ISO will  resign  at
              closing and be replaced by the current  directors  of the Company.
              The Exchange  Agreement  also  contemplates  that,  following  the
              closing of ISO's  acquisition of the Company,  the common stock of
              ISO  will  undergo  a  1:4  reverse   split  in  which  each  then
              outstanding  common  share of ISO will be changed  into 1/4th of a
              share,  and that ISO's  corporate name will be changed to Cryocon,
              Inc.  Closing under the Exchange  Agreement is anticipated to take
              place on July 31, 2000.

              b.  Issuance of Further Debentures

              On April 15, 2000, the Board of Directors  unanimously  authorized
              the  execution of a  Securities  Purchase  Agreement,  Convertible
              Debenture and related  documents with Paragon Venture Capital Fund
              IV. The  Agreement  provided for the payment of cash in the amount
              of $475,000.00. The debenture is convertible for stock immediately
              following  the closing of an  acquisition  with a publicly  traded
              shell for 237,500 shares of common stock.

              On July 7, 2000,  Cryocon  executed  an  outline  of an  agreement
              setting  forth  the  terms  for  the  issuance  of  a  Convertible
              Debenture  which provides for the payment of $1,000,000;  $500,000
              upon the closing of an acquisition with ISO Block;  and,  $500,000
              within 30 days of closing.  The Debenture is convertible for stock
              with the  floor  price  set at  $3.00/share  (post the four to one
              reverse split) for a total stock issuance at 333,333 shares.

              The debenture is convertible for stock  immediately  following the
              closing  of an  acquisition  with  a  publicly  traded  shell  for
              1,294,600 shares of common stock.

 .
                                      F-13


<PAGE>





                                  EXHIBIT INDEX

Exhibit No.                        Description


2.1      Agreement  and  Plan of Reorganization,  dated as of April 25, 2000, by
         and among the Registrant and Cryocon.







© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission